Digital Health in Cardiac Rehabilitation and Secondary Prevention: A Search for the Ideal Tool

Overview

Journal Sensors (Basel)

Publisher MDPI

Specialty Biotechnology

Date 2020 Dec 30

PMID 33374985

Citations 12

Authors

Maarten Falter

Martijn Scherrenberg

Paul Dendale

Affiliations

Soon will be listed here.

Abstract

Digital health is becoming more integrated in daily medical practice. In cardiology, patient care is already moving from the hospital to the patients' homes, with large trials showing positive results in the field of telemonitoring via cardiac implantable electronic devices (CIEDs), monitoring of pulmonary artery pressure via implantable devices, telemonitoring via home-based non-invasive sensors, and screening for atrial fibrillation via smartphone and smartwatch technology. Cardiac rehabilitation and secondary prevention are modalities that could greatly benefit from digital health integration, as current compliance and cardiac rehabilitation participation rates are low and optimisation is urgently required. This viewpoint offers a perspective on current use of digital health technologies in cardiac rehabilitation, heart failure and secondary prevention. Important barriers which need to be addressed for implementation in medical practice are discussed. To conclude, a future ideal digital tool and integrated healthcare system are envisioned. To overcome personal, technological, and legal barriers, technological development should happen in dialog with patients and caregivers. Aided by digital technology, a future could be realised in which we are able to offer high-quality, affordable, personalised healthcare in a patient-centred way.

Citing Articles

Identifying Elements for a Cardiac Rehabilitation Program for Caregivers: An International Delphi Consensus.

Loureiro M, Duarte J, Mendes E, Oliveira I, Coutinho G, Martins M Healthcare (Basel). 2024; 12(20).

PMID: 39451464 PMC: 11506942. DOI: 10.3390/healthcare12202049.

Effects of different rehabilitation modality on cardiopulmonary function in patients with acute coronary syndrome after revascularization.

Chen W, Feng Y, Yu M, Zhang Z, Wu J, Liu W Front Cardiovasc Med. 2024; 10:1120665.

PMID: 38500679 PMC: 10945546. DOI: 10.3389/fcvm.2023.1120665.

Management of Patients Affected by Giant Cell Arteritis during the COVID-19 Pandemic: Telemedicine Protocol TELEMACOV.

Parisi S, Ditto M, Talotta R, Lagana A, Peroni C, Fusaro E J Pers Med. 2023; 13(4).

PMID: 37109006 PMC: 10145002. DOI: 10.3390/jpm13040620.

Remote maintenance cardiac rehabilitation (MAINTAIN): A protocol for a randomised feasibility study.

Denton F, Waddell A, Kite C, Hesketh K, Atkinson L, Cocks M Digit Health. 2023; 9:20552076231152176.

PMID: 36818155 PMC: 9936404. DOI: 10.1177/20552076231152176.

Effectiveness of home-based upper limb rehabilitation in stroke survivors: A systematic review and meta-analysis.

Toh S, Chia P, Fong K Front Neurol. 2022; 13:964196.

PMID: 36188398 PMC: 9521568. DOI: 10.3389/fneur.2022.964196.

References

Stehlik J, Schmalfuss C, Bozkurt B, Nativi-Nicolau J, Wohlfahrt P, Wegerich S . Continuous Wearable Monitoring Analytics Predict Heart Failure Hospitalization: The LINK-HF Multicenter Study. Circ Heart Fail. 2020; 13(3):e006513. DOI: 10.1161/CIRCHEARTFAILURE.119.006513. View

Vettoretti M, Cappon G, Facchinetti A, Sparacino G . Advanced Diabetes Management Using Artificial Intelligence and Continuous Glucose Monitoring Sensors. Sensors (Basel). 2020; 20(14). PMC: 7412387. DOI: 10.3390/s20143870. View

Gehi A, Ali S, Na B, Whooley M . Self-reported medication adherence and cardiovascular events in patients with stable coronary heart disease: the heart and soul study. Arch Intern Med. 2007; 167(16):1798-803. PMC: 2789555. DOI: 10.1001/archinte.167.16.1798. View

Coughlin L, Tegge A, Sheffer C, Bickel W . A Machine-Learning Approach to Predicting Smoking Cessation Treatment Outcomes. Nicotine Tob Res. 2018; 22(3):415-422. PMC: 7297111. DOI: 10.1093/ntr/nty259. View

McManus R, Mant J, Franssen M, Nickless A, Schwartz C, Hodgkinson J . Efficacy of self-monitored blood pressure, with or without telemonitoring, for titration of antihypertensive medication (TASMINH4): an unmasked randomised controlled trial. Lancet. 2018; 391(10124):949-959. PMC: 5854463. DOI: 10.1016/S0140-6736(18)30309-X. View

Luscher J, Berli C, Schwaninger P, Scholz U . Smoking cessation with smartphone applications (SWAPP): study protocol for a randomized controlled trial. BMC Public Health. 2019; 19(1):1400. PMC: 6819348. DOI: 10.1186/s12889-019-7723-z. View

Koehler F, Koehler K, Deckwart O, Prescher S, Wegscheider K, Kirwan B . Efficacy of telemedical interventional management in patients with heart failure (TIM-HF2): a randomised, controlled, parallel-group, unmasked trial. Lancet. 2018; 392(10152):1047-1057. DOI: 10.1016/S0140-6736(18)31880-4. View

Corral-Acero J, Margara F, Marciniak M, Rodero C, Loncaric F, Feng Y . The 'Digital Twin' to enable the vision of precision cardiology. Eur Heart J. 2020; 41(48):4556-4564. PMC: 7774470. DOI: 10.1093/eurheartj/ehaa159. View

Maor E, Sara J, Orbelo D, Lerman L, Levanon Y, Lerman A . Voice Signal Characteristics Are Independently Associated With Coronary Artery Disease. Mayo Clin Proc. 2018; 93(7):840-847. DOI: 10.1016/j.mayocp.2017.12.025. View

10.

Solomon M, Leong T, Levin E, Rana J, Jaffe M, Sidney S . Cumulative Adherence to Secondary Prevention Guidelines and Mortality After Acute Myocardial Infarction. J Am Heart Assoc. 2020; 9(6):e014415. PMC: 7335507. DOI: 10.1161/JAHA.119.014415. View

11.

Lin H, Yi J . Current Status of HbA1c Biosensors. Sensors (Basel). 2017; 17(8). PMC: 5579747. DOI: 10.3390/s17081798. View

12.

Ponikowski P, Voors A, Anker S, Bueno H, Cleland J, Coats A . 2016 ESC Guidelines for the Diagnosis and Treatment of Acute and Chronic Heart Failure. Rev Esp Cardiol (Engl Ed). 2016; 69(12):1167. DOI: 10.1016/j.rec.2016.11.005. View

13.

Subramanian S, Pamplin J, Hravnak M, Hielsberg C, Riker R, Rincon F . Tele-Critical Care: An Update From the Society of Critical Care Medicine Tele-ICU Committee. Crit Care Med. 2020; 48(4):553-561. DOI: 10.1097/CCM.0000000000004190. View

14.

Kotseva K, De Backer G, De Bacquer D, Ryden L, Hoes A, Grobbee D . Lifestyle and impact on cardiovascular risk factor control in coronary patients across 27 countries: Results from the European Society of Cardiology ESC-EORP EUROASPIRE V registry. Eur J Prev Cardiol. 2019; 26(8):824-835. DOI: 10.1177/2047487318825350. View

15.

Perez M, Mahaffey K, Hedlin H, Rumsfeld J, Garcia A, Ferris T . Large-Scale Assessment of a Smartwatch to Identify Atrial Fibrillation. N Engl J Med. 2019; 381(20):1909-1917. PMC: 8112605. DOI: 10.1056/NEJMoa1901183. View

16.

Khurshid S, Healey J, McIntyre W, Lubitz S . Population-Based Screening for Atrial Fibrillation. Circ Res. 2020; 127(1):143-154. PMC: 7388078. DOI: 10.1161/CIRCRESAHA.120.316341. View

17.

Scherrenberg M, Frederix I, De Sutter J, Dendale P . Use of cardiac telerehabilitation during COVID-19 pandemic in Belgium. Acta Cardiol. 2020; 76(7):773-776. DOI: 10.1080/00015385.2020.1786625. View

18.

Piepoli M, Hoes A, Agewall S, Albus C, Brotons C, Catapano A . 2016 European Guidelines on cardiovascular disease prevention in clinical practice: The Sixth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted by.... Eur Heart J. 2016; 37(29):2315-2381. PMC: 4986030. DOI: 10.1093/eurheartj/ehw106. View

19.

Brahmbhatt D, Cowie M . Remote Management of Heart Failure: An Overview of Telemonitoring Technologies. Card Fail Rev. 2019; 5(2):86-92. PMC: 6545972. DOI: 10.15420/cfr.2019.5.3. View

20.

Cowie M, Bax J, Bruining N, Cleland J, Koehler F, Malik M . e-Health: a position statement of the European Society of Cardiology. Eur Heart J. 2015; 37(1):63-6. PMC: 5841216. DOI: 10.1093/eurheartj/ehv416. View